Molecular Pathology Research on Blood Tumors
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 July 2024 | Viewed by 238
Special Issue Editor
2. Department of Laboratory Medicine and Anatomical Pathology, University Hospital of Modena—Polyclinic, Modena, Italy
Interests: pathology oncology gynecology; human papilloma virus (HPV); epstein–barr virus (EBV); human herpes virus 8 (HHV8); coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome (SARS); middle east respiratory syndrome (MERS); nipah virus ebola virus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The World Health Organization (WHO)’s medical advances contribute to updating the famous WHO Blue Books, a series of 15 books that classify up to 300 tumor histotypes according to their definition, code, synonyms, epidemiology, localization, clinical features, etiology, macroscopy, microscopy, cytochemistry, immunophenotype, ultrastructure, genetics, prognostic factors, and predictive factors. Among these tumors, there are undoubtably those belonging to the hematopoietic and lymphoid tissues, which constitute the pathological basis of modern oncohematology. In 2022, the WHO Blue Book of hematolymphoid neoplasms has undergone a significant revision by an editorial board that was mostly composed of histopathologists and molecular pathologists, which was inserted in the fifth edition of the WHO classification for hematolymphoid tumors. The main purpose of this Special Issue is to focus, on a molecular level, on research on all these blood tumors.
Dr. Luca Roncati
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular pathology
- molecular tumor board
- blood tumors
- leukemia
- myeloma
- lymphoma
- next-generation sequencing
- precision oncology
- targeted therapy
- personalized medicine
